scholarly journals Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Chongxian Pan ◽  
Hongtao Liu ◽  
Elizabeth Robins ◽  
Wenru Song ◽  
Delong Liu ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Next Generation

Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy

2021 ◽  
Author(s):  
Chuan Liu ◽  
Guangwei Zhang ◽  
Kanghui Xiang ◽  
Yohan Kim ◽  
Roxane R. Lavoie ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Immune Checkpoint ◽  
Next Generation

Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012

2013 ◽  
Vol 62 (5) ◽  
pp. 975-981 ◽  
Author(s):  
Björn-Philipp Kloke ◽  
Sarah Kutscher ◽  
Richard Rae ◽  
Pia Kvistborg ◽  
Cedrik M. Britten ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Annual Meeting ◽  
Next Generation ◽  
10Th Annual Meeting

scholarly journals The era of bioengineering: how will this affect the next generation of cancer immunotherapy?

2017 ◽  
Vol 15 (1) ◽  
Author(s):  
Michele Graciotti ◽  
Cristiana Berti ◽  
Harm-Anton Klok ◽  
Lana Kandalaft
Keyword(s):  
Cancer Immunotherapy ◽  
Next Generation

scholarly journals Next generation of cancer immunotherapy calls for combination

Oncoscience ◽  
2017 ◽  
Vol 4 (3-4) ◽  
pp. 19-20 ◽  
Author(s):  
Paola Cappello ◽  
Francesco Novelli
Keyword(s):  
Cancer Immunotherapy ◽  
Next Generation

scholarly journals Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy

Cancers ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 1302 ◽  
Author(s):  
Claudia Arndt ◽  
Frederick Fasslrinner ◽  
Liliana R. Loureiro ◽  
Stefanie Koristka ◽  
Anja Feldmann ◽  
...  
Keyword(s):  
T Cell ◽  
Cancer Immunotherapy ◽  
Chimeric Antigen Receptor ◽  
Modular Design ◽  
Antigen Receptor ◽  
Hematologic Malignancies ◽  
Recombinant Antibodies ◽  
Next Generation ◽  
Clinical Experiences

The success of conventional chimeric antigen receptor (CAR) therapy in the treatment of refractory hematologic malignancies has triggered the development of novel exciting experimental CAR technologies. Among them, adaptor CAR platforms have received much attention. They combine the flexibility and controllability of recombinant antibodies with the power of CARs. Due to their modular design, adaptor CAR systems propose answers to the central problems of conventional CAR therapy, such as safety and antigen escape. This review provides an overview on the different adaptor CAR platforms available, discusses the possibilities and challenges of adaptor CAR therapy, and summarizes the first clinical experiences.

Abstract LB-287: Pseudocowpox: A next generation viral vector for cancer immunotherapy

2018 ◽  
Author(s):  
Karola Rittner ◽  
Marine Ricordel ◽  
Caroline Tosch ◽  
Christine Thioudellet ◽  
Christelle Remy-Ziller ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Viral Vector ◽  
Next Generation

scholarly journals Next-Generation Cancer Immunotherapy Targeting Glypican-3

2019 ◽  
Vol 9 ◽  
Author(s):  
Yasuhiro Shimizu ◽  
Toshihiro Suzuki ◽  
Toshiaki Yoshikawa ◽  
Itaru Endo ◽  
Tetsuya Nakatsura
Keyword(s):  
Cancer Immunotherapy ◽  
Next Generation
Sign in / Sign up

Export Citation Format

Share Document